Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash from Operations: 2010-2025

Historic Cash from Operations for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $20.1 million.

  • Cross Country Healthcare's Cash from Operations rose 16926.37% to $20.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.7 million, marking a year-over-year decrease of 6497.01%. This contributed to the annual value of $120.1 million for FY2024, which is 5166.32% down from last year.
  • As of Q3 2025, Cross Country Healthcare's Cash from Operations stood at $20.1 million, which was up 16926.37% from $4.2 million recorded in Q2 2025.
  • Cross Country Healthcare's 5-year Cash from Operations high stood at $140.6 million for Q3 2022, and its period low was -$73.4 million during Q4 2021.
  • For the 5-year period, Cross Country Healthcare's Cash from Operations averaged around $23.5 million, with its median value being $12.1 million (2023).
  • As far as peak fluctuations go, Cross Country Healthcare's Cash from Operations tumbled by 390326.59% in 2021, and later skyrocketed by 506739.67% in 2022.
  • Quarter analysis of 5 years shows Cross Country Healthcare's Cash from Operations stood at -$73.4 million in 2021, then soared by 105.89% to $4.3 million in 2022, then surged by 179.49% to $12.1 million in 2023, then skyrocketed by 100.71% to $24.2 million in 2024, then decreased by 17.0% to $20.1 million in 2025.
  • Its last three reported values are $20.1 million in Q3 2025, $4.2 million for Q2 2025, and $5.7 million during Q1 2025.